EphA3 antibodies for the treatment of solid tumors

Details for Australian Patent Application No. 2008226905 (hide)

International Classifications

Event Publications

17 September 2009 PCT application entered the National Phase

PCT publication WO2008/112192 Priority application(s): WO2008/112192

16 February 2012 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read Scott, Andrew Mark; Lackmann, Martin; Yarranton, Geoffrey T.; Bebbington, Christopher R. and Murone, Carmelina 2009

16 February 2012 Alteration of Name

The name of the applicant has been altered to KaloBios Pharmaceuticals, Inc.; Ludwig Institute for Cancer Research; Monash University Amendments

23 February 2012 Corrigenda

Amendments - Amendments Made Under the Name KaloBios Pharmaceuticals, Inc.; Ludwig Institute for Cancer Research and Monash University, Application No. 2008226905, Under INID (72) correct the inventor to Scott, Andrew Mark; Lackmann, Martin; Yarranton, Geoffrey T.; Bebbington, Christopher R.; Murone, Carmelina and To, Catherine Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journa

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.